Carolin Daniel is a Principal Investigator at Helmholtz Munich and a Professor at Ludwig-Maximilians Universität München. Their laboratory focuses on understanding the cellular and molecular mechanisms of immune tolerance in autoimmune Type 1 Diabetes. Carolin previously led the Research Group Immune Tolerance in Diabetes at Helmholtz Zentrum München from 2012 to 2022 and completed postdoctoral research at Harvard Medical School and Dana-Farber Cancer Institute from 2008 to 2012. They hold a fellowship from the Leopoldina, National Academy of Sciences in Germany.
This person is not in the org chart
This person is not in any teams
This person is not in any offices